iSBTc 23rd Annual Meeting
October 31 - November 2, 2008
Westin Gaslamp Quarter Hotel
San Diego, CA
Schedule at a Glance (subject to change)
| Friday, October 31 |
| 6:00 am - 6:00 pm |
Registration Open |
| 7:00 am - 8:00 am |
Continental Breakfast |
| 7:50 am - 8:00 am |
President's Welcome
Jon M. Wigginton, MD - Merck & Co., Inc.
|
| 8:00 am - 8:45 am |
Richard V. Smalley, MD, Memorial Lectureship
Giorgio Parmiani, MD - San Raffaele Foundation
|
| 8:45 am - 11:30 am |
Plenary Session: Enhancing Cancer Vaccines
Co-Chairs/ Invited Speakers: |
Glenn Dranoff, MD - Dana-Farber Cancer Institute
W. Martin Kast, PhD - University of Southern California
|
|
| 11:30 am - 1:00 pm |
Lunch with Poster Viewing |
| 1:00 pm - 3:00 pm |
Plenary Session: Adoptive Transfer
| Co-Chairs: |
Helen E. Heslop, MD - Baylor College of Medicine
William J. Murphy, PhD - University of Nevada, School of Medicine
|
| Invited Speakers: |
Michael Jensen, MD - City of Hope, Beckman Research Institute
Nicholas P. Restifo, MD - National Cancer Institute
|
|
| 3:15 pm - 4:45 pm |
Concurrent Session I: TH-17, Cytokines and T Cell Subsets
| Co-Chairs: |
Martin Oft - Schering-Plough Biopharma (formerly DNAX)
Hideaki Tahara, MD, PhD - University of Tokyo
|
| Invited Speakers: |
Ilona Kryczek, PhD - University of Michigan
Martin Oft - Schering-Plough Biopharma (formerly DNAX)
Hideaki Tahara, MD, PhD - University of Tokyo
|
|
| 3:15 pm - 4:45 pm |
Concurrent Session II: Endpoints, Response Criteria for Clinical Trial Design
| Co-Chairs: |
Thomas A. Davis, MD - Celldex Therapeutics, Inc.
Jeffrey Schlom, PhD - National Cancer Institute, NIH
|
| Invited Speakers: |
TBA
TBA
|
|
| 4:45 pm - 5:15 pm |
Membership Business Meeting |
| 5:15 pm - 7:00 pm |
Reception with Poster Viewing |
| |
|
| Saturday, November 1 |
| 7:00 am - 6:00 pm |
Registration Open |
| 7:00 am - 8:00 am |
Continental Breakfast |
| 8:00 am - 8:45 am |
Keynote Address
Robert D. Schreiber, PhD - Washington University in St. Louis
|
| 8:45 am - 11:30 am |
Plenary Session: Tumor Escape / Tumor Microenvironment
| Co-Chairs: |
Thomas F. Gajewski, MD, PhD - University of Chicago
Weiping Zou, MD, PhD - University of Michigan
|
| Invited Speakers: |
Thomas F. Gajewski, MD, PhD - University of Chicago
Pierre van der Bruggen, PhD - Ludwig Institute for Cancer Research
Weiping Zou, MD, PhD - University of Michigan
|
|
| 11:30 am - 1:00 pm |
Lunch with Poster Viewing |
| 1:00 pm - 2:20 pm |
iSBTc Presidential Session
| Chair: |
Jon M. Wigginton, MD - Merck & Co., Inc.
|
|
| 2:45 pm - 4:15 pm |
Concurrent Session I: Tumor Targeting Monoclonal Antibodies
| Co-Chairs: |
Helen Chen, MD - National Cancer Institute, CTEP
Greg Lazar, PhD - Xencor, Inc.
|
| Invited Speakers: |
John C. Byrd, MD - The Ohio State University
John R. Desjarlais, PhD - Xencor, Inc.
|
|
| 2:45 pm - 4:15 pm |
Concurrent Session II: Innate Immunity to Tumors
Co-Chairs/
Invited Speakers: |
David Raulet, PhD - University of California, Berkeley
Giorgio Trinchieri, MD - National Cancer Institute
|
|
| 4:15 pm - 4:45 pm |
Award Presentations |
| 4:45 pm - 6:30 pm |
Presidential Reception with Poster Viewing |
| |
|
| Sunday, November 2 |
| 7:00 am - 11:00 am |
Registration Open |
| 7:00 am - 8:00 am |
Continental Breakfast |
| 8:00 am - 8:45 am |
Update: 2007 Workshop on Future Opportunities for Combination Biological
Therapy of Cancer
| Speaker: |
Jon M. Wigginton, MD - Merck & Co., Inc.
|
|
| 8:45 am - 11:00am |
Plenary Session: Cancer Stem Cell and the Host Response
Co-Chairs/ Invited Speakers: |
Madhav Dhodapkar, MD - The Rockefeller University
Max Wicha, MD - University of Michigan
|
|
|